Study

Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry. – Cost Effective Supplements

Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/16046102


Conclusion of this study

Psychometric tests concerning noopsychic and thymopsychic measures as well as critical flicker fusion frequency generally demonstrated a lack of differences between SAMe and placebo, which reflects a good tolerability of the drug in elderly subjects. This was corroborated by the findings on side effects, pulse and blood pressure.


Supplements analyzed in this study

SAME

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Mental health


Slightly Negative
SAME


Body systems related to this study


Nervous System
Scroll to top